Feature | March 11, 2010

Hybrid Cath Lab Exhibit at ACC Highlights Growing Trend

March 12, 2010 – In partnership with the American College of Cardiology (ACC), Philips is spotlighting the growing need for hybrid cath labs with a specialty exhibit during ACC 2010 March 14-16 in Atlanta. The need to reduce invasive surgical interventions and complication rates is driving innovations in minimally invasive approaches. Philips and ACC will jointly showcase the Hybrid OR Suite on the expo floor, a solution that combines in one room the equipment needed to perform both open and endovascular cardiac procedures. Built out of combined efforts by Philips and its network of alliances, the Hybrid OR Suite will help advance how clinicians attend to patients in cardiac procedures. Traditionally, X-ray imaging is used to navigate cardiac interventions performed in a cardiac catheterization lab. In recent times, importance has grown for 3D ultrasound imaging in visualizing complex structures during interventions. A hybrid OR suite combines the sterility and instruments of a traditional operating room with the X-ray and ultrasound imaging systems and radiation shields of a cath lab. “Using live 3D TEE ultrasound, we can view the anatomy without incisions or surgery,” said Roberto Lang, M.D., director of noninvasive cardiac imaging labs at the University of Chicago Medical Center. “It provides 3D images unlike those from other technology, to help clinicians place therapeutic devices." The cutting-edge hybrid OR configuration not only provides hospitals with a room that is flexible enough to handle a wide variety of treatments and procedures, but it also helps clinicians from a variety of specialties to collaborate. "Multidisciplinary care is gaining broader acceptance as hospitals and healthcare institutions combine approaches and evolve in their delivery of cardiac care,” said Henry Solomon, M.D., chief medical officer for business development at the American College of Cardiology. “Rooms equipped to support both open surgical and minimally invasive endovascular approaches, such as the hybrid OR, are designed to meet the specific needs of clinicians when they are called upon to perform difficult procedures.” The hybrid OR suite on display at this year’s ACC enables clinicians to perform a full range of endovascular, percutaneous and open procedures. Percutaneous procedures enable physicians to utilize minimally invasive catheter-based interventions to treat patients that may be too sick or frail for open interventions, such as in valve replacement surgery. “The patient is happy, the procedure is less invasive and the collaboration between the cardiologist, the cardiac surgeons and industry—with Philips providing the technology—has made that possible,” said Valluvan Jeevanandam, M.D., chief of cardiac and thoracic surgery at the University of Chicago Medical Center. Philips’ hybrid OR suites are customized for customer needs and designed using an advanced 3D architectural planning tool that provides prospective customers with a visual rendering of possible room configurations. From high-quality, high-resolution, multimodality imaging with advanced 3D software to support confident decision-making, to surgical tables, lighting and other equipment considerations, the full scope of equipment combinations is assessed. The Philips Healthcare booth is 1343, and the Hybrid OR Suite is located in booth 2744. Online visitors can visit http://www.philips.com/media or www.philips.com/hybridor

Related Content

Acutus Medical, AcQMap EP Imaging and Mapping System, CE Mark
News | EP Mapping and Imaging Systems| May 04, 2016
Acutus Medical announced CE Mark approval for its AcQMap High Resolution Imaging and Mapping System and AcQMap Catheter...
aortic valve reconstruction, surgery, PinnacleHealth, Pennsylvania
News | Cardiovascular Surgery| May 04, 2016
Three PinnacleHealth patients recently underwent a new procedure for aortic valve reconstruction using the patients'...
FDA, CDRH, national evaluation system, medical device development
Feature | Business| May 04, 2016
The U.S. Food and Drug Administration (FDA) announced it is building the foundations of a national evaluation system to...
Biotronik, FDA, MR Conditional CRT devices, Iperia HF-T, defibrillator, ProMRI
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 03, 2016
Biotronik announced U.S. Food and Drug Administration (FDA) approval of Iperia ProMRI HF-T, a cardiac resynchronization...
radiation dose in the cath lab
News | Radiation Dose Management| May 02, 2016
May 2, 2016 — Starting at the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 annual meeting May
AtriCure, AtriClip PRO2 LAA Exclusion System, left atrial appendage, FDA clearance
Technology | Left Atrial Appendage (LAA) Occluders| April 29, 2016
April 29, 2016 — AtriCure Inc. announced U.S.
microtubules, heartbeat mechanics, Perelman School of Medicine study

Microtubules in a cardiomyocyte at rest (top) and when compressed. Image courtesy of the lab of Ben Prosser, Ph.D., Perelman School of Medicine, University of Pennsylvania

News | EP Lab| April 29, 2016
Using new high-resolution microscopy, researchers have found that molecular struts called microtubules (MT) interact...
Boston Scientific, FDA, ImageReady MR-Conditional Pacing System
Technology | EP Lab| April 28, 2016
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for a suite of products deemed safe for...
Feature | Business| April 28, 2016 | Dave Fornell
 
Technology | Stents Peripheral| April 27, 2016
Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a patient suffering...
Overlay Init